Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas.

bioRxiv : the preprint server for biology(2023)

Cited 0|Views32
No score
Abstract
Broad target inhibition effective as a salvage strategy in BRAF/MEK inhibitor-acquired resistance PDX.
More
Translated text
Key words
mapk,standard-of-care
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined